Pasar al contenido principal

Células dendríticas y macrófagos intestinales humanos en la enfermedad inflamatoria intestinal.

RYC-2017-21606

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VALLADOLID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

BURJC-Digital. Repositorio Institucional de la Universidad Rey Juan Carlos
Publicación Artículo científico (JournalArticle)

Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates Between Type and Mucosal Status in Patients With Inflammatory Bowel Disease

  • Ortega Moreno, Lorena
  • Fernández-Tomé, Samuel
  • Chaparro, María
  • Marin, Alicia C
  • Mora-Gutierrez, Irene
  • Santander, Cecilio
  • Baldan-Martin, Montse
  • Gisbert, Javier P.
  • Bernardo, David
[Background]: Intestinal dendritic cells (DC) and macrophages drive disease progression in patients with inflammatory bowel disease (IBD). We aimed to characterize the activation and homing profile of human circulating DC and monocyte subsets in healthy control patients (CP) and IBD patients., This work was supported by the Spanish Ministry of Science (SAF2014-56642-JIN; RYC-2017–21606), the Instituto de Salud Carlos III (PIE13/00041), the Sara Borrell fellowship CD17/00014), the Asociación Española de Gastroenterología (Becas Nuevos Investigadores 2016), and the Community of Madrid (Consejería de Educación, Juventud y Deporte, Programa de Garantía Juvenil 2015 and 2016; Universidad Autónoma de Madrid, Ayudas Atracción de Talento modalidad 2 2017 [BMD-5800]).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immunomodulatory effect of gut microbiota-derived bioactive peptides on human immune system from healthy controls and patients with inflammatory bowel disease

  • Fernández-Tomé, Samuel
  • Marin, Alicia C.
  • Ortega Moreno, Lorena
  • Baldan-Martin, Montserrat
  • Mora-Gutiérrez, Irene
  • Lanas-Gimeno, Aitor
  • Moreno-Monteagudo, J. A.
  • Santander, Cecilio
  • Sánchez García, Borja
  • Chaparro, María
  • Gisbert, Javier P.
  • Bernardo, David
Bioactive peptides secreted by probiotic Bifidobacterium longum (peptide B7) and opportunistic pathogen Bacteroides fragilis (peptide B12) modulate the intestinal cytokine milieu in health. Here, we characterized their capacity to modulate both the mucosal cytokine production and the phenotype of circulating antigen presenting cells (APCs) in active inflammatory bowel disease (IBD). The IBD mucosa produced higher levels of pro-inflammatory cytokines referred to healthy controls (HCs). Peptides B7 and B12, however, did not ameliorate the mucosal cytokine milieu in IBD. Human circulating APCs (B-cells, monocytes, plasmacytoid dendritic cells (pDCs), and conventional dendritic cells (cDCs)) were characterized by flow cytometry in presence/absence of the peptides. Circulating B-cells, monocytes, and cDCs from IBD patients were more activated than those from HCs. Peptide B7, but not B12, decreased CCR2 expression on all APC subsets from HC, but not IBD patients. Moreover, both peptides tend to further increase their pro-inflammatory profile in IBD. In summary, IBD patients display mucosal and circulating APC pro-inflammatory properties. Peptide B7 immunomodulatory capacity elicited over circulating APCs from HC, but not IBD patients, suggests the presence of disrupted modulatory mechanisms for this peptide in IBD. Future studies should address the effect of bacteria-derived immunomodulatory peptides in non-inflamed (quiescent) IBD patients., S.F.T. is currently funded by the Instituto de Salud Carlos III (Sara Borrell fellowship CD17/00014). L.O.M. is funded by the Community of Madrid (BMD-5800). D.B. is funded by the Spanish Ministry of Science (RYC-2017-21606). This work was supported by the Spanish Ministry of Economy (SAF2014-56642-JIN), the Spanish Ministry of Health (PIE13/00041), GETECCU (Grupo Español de Trabajo en Enfermedad Crohn y Colitis Ulcerosa), and the Community of Madrid (Consejería de Educación, Juventud y Deporte, Programa de Garantía Juvenil 2015 and 2016)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Circulating dendritic cells from celiac disease patients display a gut‐homing profile and are differentially modulated by different gliadin‐derived peptides

  • Escudero-Hernández, Celia
  • Martín, Álvaro
  • Pedro Andrés, Rodrigo de
  • Fernández-Salazar, Luis
  • Garrote, José Antonio
  • Bernardo, David
  • Arranz, Eduardo
[Scope]: Circulating dendritic cell (DC) and monocyte subsets contribute to the pool of intestinal DC and macrophages in celiac disease (CeD), an autoimmune gut disorder triggered by dietary gluten. Here, this study aims to characterize these circulating subsets in CeD and assess the effect of different gliadin‐derived peptides on conventional DC (cDC)., [Methods and results]: Flow cytometry profiling of peripheral blood mononuclear cells reveals a slight decrease in the proportion of plasmacytoid and type 1 cDC in gluten‐free diet (GFD)‐treated CeD patients. In comparison to healthy donors, DC and monocyte subsets from active and GFD‐treated CeD patients display an increased gut‐homing profile. Type 2 cDC (cDC2) are sorted and stimulated with the gliadin‐derived peptides 8‐mer, 19‐mer, and 33‐mer. All peptides induce cDC2 maturation, although the profile is different. While peptide 8‐mer induces a Th1/Th17 pro‐inflammatory cytokine profile in active CeD patients, cDC2 primed with peptide 33‐mer displays a higher capacity to promote gut‐homing CCR9+ expression onto autologous T‐cells., [Conclusion]: Distinct gliadin‐derived peptides elicit different effects on cDC2 phenotype and function. This effect is compatible with a model where diverse gliadin peptides may cooperate to promote full cDC2 activation and the subsequent T‐cell response in genetically predisposed individuals., This research was financially supported by Asociación de Celiacos y Sensibles al Gluten de Madrid (Spain), the Spanish Ministry of Science (RYC‐2017‐21606), and the Spanish Ministry of Economics and Competitiveness (RTC‐2014‐2401)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Serum adipokines as non-invasive biomarkers in Crohn’s disease

  • Ortega Moreno, Lorena
  • Sanz‑Garcia, Ancor
  • Fernández de la Fuente, Marina J.
  • Arroyo Solera, Ricardo
  • Fernández-Tomé, Samuel
  • Marin, Alicia C.
  • Mora-Gutiérrez, Irene
  • Fernández, Paloma
  • Baldan-Martin, Montserrat
  • Chaparro, María
  • Gisbert, Javier P.
  • Bernardo, David
© The Author(s) 2020., Adipose tissue secretes molecules that can promote activity in Crohn’s disease. We aimed to evaluate the role of serum adipokines as possible biomarkers in Crohn’s disease. Serum samples were obtained from 40 patients with endoscopically active or quiescent Crohn’s disease and 36 healthy controls. Serum leptin, ghrelin, resistin and adiponectin levels were analysed by Multiplex in a Luminex 200 system technology. Receiver Operating Characteristic curves were performed to evaluate the adipokines discriminatory capacity. A logistic regression adjusted by possible confounders (i.e. gender, age, BMI) was performed for those adipokines that showed an area under the curve > 0.7. No differences were found in age, gender or BMI among groups. Distribution for serum resistin was different among the three groups of study, and only this adipokine showed an area under the curve of 0.75 comparing actives patients and healthy control groups. Resistin median concentration was selected as a cut-off for a logistic regression analysis; odds ratio along its 95% confidence interval adjusted by gender, age, and BMI yielded a value of 5.46 (1.34–22.14) comparing actives patients and healthy controls. High concentration of serum resistin is probably associated to activity, being this association independent of gender, age or BMI., This work was supported by Ayudas Atracción de Talento modalidad 2 2017, BMD-5800 (Universidad Autónoma de Madrid and Comunidad de Madrid), the Ramón y Cajal Research Programme from the Spanish Ministry of Science (RYC-2017-21606), and the Sara Borrell fellowship from the Instituto de Salud Carlos III (CD17/00014). This study was possible thanks to Dr. Domingo Barber, scientifc director of Instituto de Medicina Molecular Aplicada (IMMA), Facultad de Medicina, Universidad San Pablo CEU, Madrid, Spain.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Profiling of Human Circulating Dendritic Cells and Monocyte Subsets Discriminates between Type and Mucosal Status in Patients with Inflammatory Bowel Disease

  • Ortega Moreno, Lorena
  • Fernández-Tomé, Samuel
  • Chaparro, María
  • Marin, Alicia C.
  • Mora-Gutiérrez, Irene
  • Santander, Cecilio
  • Baldan-Martin, Montserrat
  • Gisbert, Javier P.
  • Bernardo, David
[Background]: Intestinal dendritic cells (DC) and macrophages drive disease progression in patients with inflammatory bowel disease (IBD). We aimed to characterize the activation and homing profile of human circulating DC and monocyte subsets in healthy control patients (CP) and IBD patients., [Methods]: Eighteen CP and 64 patients with IBD were categorized by diagnoses of Crohn disease (CD) and ulcerative colitis (UC), either endoscopically active (inflamed) or quiescent. Circulating type 1 conventional DC, type 2 conventional DC, plasmacytoid DC, classical monocytes, nonclassical monocytes, and intermediate monocytes were identified by flow cytometry in each individual and characterized for the expression of 18 markers. Association between DC/monocytes and IBD risk was tested by logistic regression. Discriminant canonical analyses were performed to classify the patients in their own endoscopy category considering all markers on each subset., [Results]: CCRL1, CCR3, and CCR5 expression on circulating type 1 DC; CCRL1 expression on nonclassical monocytes; and CCR9 and β7 expression on classical monocytes allowed us to discriminate among the different study groups. Indeed, the same markers (excluding β7) were also associated with IBD when all DC and monocyte subsets were considered at the same time., [Conclusions]: Monitoring the phenotype of human circulating DC and monocyte subsets may provide novel tools as biomarkers for disease diagnosis (CD/UC) or mucosal status (inflamed/noninflamed) in the absence of an invasive colonoscopy., This work was supported by the Spanish Ministry of Science (SAF2014-56642-JIN; RYC-2017–21606), the Instituto de Salud Carlos III (PIE13/00041), the Sara Borrell fellowship CD17/00014), the Asociación Española de Gastroenterología (Becas Nuevos Investigadores 2016), and the Community of Madrid (Consejería de Educación, Juventud y Deporte, Programa de Garantía Juvenil 2015 and 2016; Universidad Autónoma de Madrid, Ayudas Atracción de Talento modalidad 2 2017 [BMD-5800]).